Not applicable.
Not applicable.
Encapsulated protective suits may be worn in contaminated areas to protect the wearer of the suit. For example, workers may wear an encapsulated protective suit while working inside of a nuclear powered electrical generating plant or in the presence of radioactive materials. An encapsulated protective suit may be a one-time use type of system, wherein after a single use the suit is disposed of. An encapsulated protective suit may receive breathing air during normal operating conditions via an external air flow hose connected to the suit. The air may be supplied, for example, by a power air purifying respirator (PAPR) that may be carried by the user.
In an embodiment, an encapsulated protective suit is disclosed. The encapsulated protective suit having an external air flow hose comprises a skin, a filter incorporated in the skin of the protective suit, and a seal, wherein when the seal is intact, air does not flow through the filter.
In an embodiment, an encapsulated protective suit is disclosed. The encapsulated protective suit having an external air flow hose comprises a skin, a filter incorporated in the skin of the protective suit, the filter having an exterior face and an interior face, where the exterior face of the filter faces towards an exterior of the protective suit and wherein the interior face of the filter faces towards an interior of the protective suit, a first seal coupled to one of the exterior of the suit or the exterior face of the filter, and a second seal coupled to one of the interior of the suit or the interior face of the filter.
In an embodiment, a method of using a fully encapsulated protective suit is disclosed. The method comprises donning a protective suit, the protective suit having an external air flow hose and comprising a skin, a filter incorporated in the skin of the protective suit, and a first seal, wherein when the first seal is intact, air does not flow out through the filter from an interior of the protective suit. The method further comprises, after donning the protective suit, breaching the first seal, and, after breaching the first seal, inhaling air received from the filter.
These and other features will be more clearly understood from the following detailed description taken in conjunction with the accompanying drawings and claims.
For a more complete understanding of the present disclosure, reference is now made to the following brief description, taken in connection with the accompanying drawings and detailed description, wherein like reference numerals represent like parts.
It should be understood at the outset that although illustrative implementations of one or more embodiments are illustrated below, the disclosed systems and methods may be implemented using any number of techniques, whether currently known or not yet in existence. The disclosure should in no way be limited to the illustrative implementations, drawings, and techniques illustrated below, but may be modified within the scope of the appended claims along with their full scope of equivalents.
Turning now to
While using the suit 100 in the contaminated environment, in an embodiment, it is preferred that a positive pressure differential be maintained between the interior and exterior of the suit 100. This positive pressure differential may provide a margin of safety, in that if a minor breach of the skin 102 occurs, contaminated material is not likely to enter the suit 100 but rather may be discouraged from entry by air flowing from the interior to the exterior of the suit 100 at the location of the minor breach. Generally it is desired that the suit 100 be relatively air-tight, with the exception of the exhaust valve described above, to promote efficiency. For example, if the normal air supply is provided by a powered air purifying respirator that is battery powered, a low efficiency encapsulated protective suit—that is a suit that has unnecessary air escape points —may cause the powered air purifying respirator to work harder to maintain the desired pressure differential and may prematurely discharge the battery. Alternatively, an inefficient suit may entail using a heavier battery in the powered air purification respirator and the disadvantages associated with excess weight.
When the powered air purifying respirator or other source of air flow fails, the user of the suit 100 may employ the first emergency breathing apparatus 104 to breathe safely. It is expected that the user of the suit 100, when normal air flow fails, will begin returning to a safe area shortly after the normal air flow source fails, and hence it is contemplated that the first emergency breathing apparatus 104 will be used for relatively short time intervals, for example for less than 2 minutes, for less than 6 minutes, or for less than 10 minutes.
Turning now to
Under normal operation, that is when the user of the encapsulated protective suit 100 is breathing air provided via an external air hose, the seal 108 blocks flow into and out of the filter 106. This blockage by the seal 108 contributes to the air-tightness of the suit 100 and promotes the efficiency of the suit 100. When emergency air supply is needed, the seal 108 is torn at least partially free of the skin 102 and/or free of the filter 106, opening a pathway for air to flow in through the filter 106, through the couplings 120, 122, up the breathing pipe 124, to the mouth piece 126. The portion of the filter 106 facing to the left in
In an embodiment, the filter 106 may be a pancake type filter. Pancake type filters are known in the art and may take a variety of different forms. In an embodiment, a pancake type filter may be substantially cylindrical in shape where the height of the cylinder is much less than the width or diameter of the cylinder. For example, in an embodiment, the height of the cylinder may be less than 20% of the width or diameter of the cylinder. Alternatively, in an embodiment, the height of the cylinder may be less than 10% of the width or diameter of the cylinder. While pancake filters may be generally circular in section, in an embodiment, the pancake filter may be polygonal in section or elliptical in section. In an embodiment, the filter 106 may be a P3 filter. Alternatively, in an embodiment, the filter 106 may be a P2 filter. Alternatively, in an embodiment, the filter 106 may be a P1 filter. As is known by one skilled in the art, a P3 filter may filter at least 99.95% of airborne particles; a P2 filter may filter at least 94% of airborne particles; and a P1 filter may filter at least 80% of airborne particles. In other embodiments, however, the filter 106 may be a different filter.
Turning now to
When the user of the encapsulated protective suit 100 wishes to use the first emergency breathing apparatus 104, the user may grasp the edge of the seal 108 and tear it downwards to breach the seal between the skin 102 and/or the filter 106 and the seal 108. It is understood that the term seal may be used to refer to the structure seal 108 that in part establishes a seal, meaning a barrier, between the exterior and interior of the suit 100 as well as to refer to the state of the existence of the barrier. When the seal 108 blocks flow into and out of the filter 106, the seal established between the seal 108 and the skin 102 and/or the filter 106 may be said to be intact. In an embodiment, the seal 108 may also be secured to the skin 102 and/or the filter 106 by a non-tearable weld 152 or other structure. As shown in
Turning now to
Turning now to
The filter 106 used in the second emergency breathing apparatus 200 may be a moisture laden or moisture bearing filter. The principle of operation of the filter 106 used in the second breathing apparatus 200 may depend upon the moisture contained within the filter 106. For example, the filter 106 in the second breathing apparatus 200 may be a tritium filter. As is known to those skilled in the art, tritium is a radioactive isotope of hydrogen that may be encountered in nuclear reactor work environments and poses significant health risks to workers who may inhale tritium. To assure that the filter 106 in the second breathing apparatus 200 remains moist, the filter 106 may be sealed in the encapsulated protective suit 100 on both an exterior and interior of the suit 100. Thus, the seal 108 may be coupled to the exterior of the skin 102 and/or the exterior of the filter 106, and the seal 202 may be coupled to the interior of the skin 102 and/or the interior of the filter 106.
Before donning the encapsulated protective suit 100, a user may tear down the seal 202. After tearing down the seal 202, the user may couple the filter air coupler 122a with the breathing pipe air coupler 122b. Then when the user needs to employ the second emergency breathing apparatus 200, for example in an emergency breathing situation, the user tears open the seal 108 and breathes through the mouthpiece 126 as described above with reference to the first emergency breathing apparatus 104. In an embodiment, a one-way air flow valve (not shown) may be incorporated in the emergency breathing apparatus 200 to permit flow through the filter 106 from the outside of the suit 100 to the inside of the suit 100, and to substantially block flow through the filter 106 from the inside of the suit 100 to the outside of the suit 100.
While several embodiments have been provided in the present disclosure, it should be understood that the disclosed systems and methods may be embodied in many other specific forms without departing from the spirit or scope of the present disclosure. The present examples are to be considered as illustrative and not restrictive, and the intention is not to be limited to the details given herein. For example, the various elements or components may be combined or integrated in another system or certain features may be omitted or not implemented.
Also, techniques, systems, subsystems, and methods described and illustrated in the various embodiments as discrete or separate may be combined or integrated with other systems, modules, techniques, or methods without departing from the scope of the present disclosure. Other items shown or discussed as directly coupled or communicating with each other may be indirectly coupled or communicating through some interface, device, or intermediate component, whether electrically, mechanically, or otherwise. Other examples of changes, substitutions, and alterations are ascertainable by one skilled in the art and could be made without departing from the spirit and scope disclosed herein.
This application is a continuation of and claims priority to U.S. patent application Ser. No. 13/278,439, filed on Oct. 21, 2011, and entitled “Emergency Filter System for Encapsulated Suit”, which is hereby incorporated by reference for all purposes as if reproduced in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
2991000 | Spees | Jul 1961 | A |
3635216 | Curtis | Jan 1972 | A |
3667459 | Durney | Jun 1972 | A |
3802594 | Lemelson | Apr 1974 | A |
3921224 | Ingram, III | Nov 1975 | A |
3946896 | Lemelson | Mar 1976 | A |
4059852 | Crane | Nov 1977 | A |
4271833 | Moretti | Jun 1981 | A |
4310926 | Maroist | Jan 1982 | A |
4460392 | Poulsen | Jul 1984 | A |
4470413 | Warncke | Sep 1984 | A |
4561162 | Brockway et al. | Dec 1985 | A |
4719911 | Carrico | Jan 1988 | A |
4864654 | Schriver et al. | Sep 1989 | A |
4901370 | Suda | Feb 1990 | A |
5062424 | Hooker | Nov 1991 | A |
5088115 | Napolitano | Feb 1992 | A |
5201309 | Friberg | Apr 1993 | A |
H1360 | Grove et al. | Oct 1994 | H |
5413567 | Barth et al. | May 1995 | A |
5660169 | Kallstrand et al. | Aug 1997 | A |
5660269 | Fujiwara | Aug 1997 | A |
5991921 | Saito | Nov 1999 | A |
6076571 | Burns | Jun 2000 | A |
6290642 | Reinhard et al. | Sep 2001 | B1 |
6349721 | Grilliot et al. | Feb 2002 | B1 |
6530374 | Ferraro | Mar 2003 | B1 |
6681589 | Brudnicki | Jan 2004 | B2 |
6758212 | Swann | Jul 2004 | B2 |
6804836 | Grilliot et al. | Oct 2004 | B2 |
7631364 | Culler | Dec 2009 | B2 |
7650885 | Paoluccio et al. | Jan 2010 | B2 |
8074299 | Brookman | Dec 2011 | B2 |
8464366 | Carron | Jun 2013 | B2 |
8476604 | Yoder | Jul 2013 | B2 |
9000913 | Patil et al. | Apr 2015 | B2 |
9186528 | Patil et al. | Nov 2015 | B2 |
9554604 | Rippert et al. | Jan 2017 | B2 |
10004925 | Tuffery | Jun 2018 | B2 |
20030045918 | Turner et al. | Mar 2003 | A1 |
20030140399 | Golde | Jul 2003 | A1 |
20030150232 | Brudnicki | Aug 2003 | A1 |
20030192103 | Avery et al. | Oct 2003 | A1 |
20040138601 | Chalmers | Jul 2004 | A1 |
20040216736 | Lee et al. | Nov 2004 | A1 |
20040226558 | Kausch | Nov 2004 | A1 |
20040237178 | Landeros | Dec 2004 | A1 |
20050010996 | Steinert | Jan 2005 | A1 |
20050011517 | Steinert | Jan 2005 | A1 |
20050015866 | Steinert | Jan 2005 | A1 |
20060021118 | Culler et al. | Feb 2006 | A1 |
20060048777 | Brookman | Mar 2006 | A1 |
20060070162 | Frank | Apr 2006 | A1 |
20060070612 | Horton et al. | Apr 2006 | A1 |
20070006607 | Hunt | Jan 2007 | A1 |
20070095088 | Drobot Isherwood et al. | May 2007 | A1 |
20070215148 | Tuffery | Sep 2007 | A1 |
20070289050 | Nocente et al. | Dec 2007 | A1 |
20080196140 | Mayerson et al. | Aug 2008 | A1 |
20090235439 | Cox et al. | Sep 2009 | A1 |
20100037891 | Walker et al. | Feb 2010 | A1 |
20120026622 | Shitara et al. | Feb 2012 | A1 |
20120036622 | Carron | Feb 2012 | A1 |
20120066819 | Carron | Mar 2012 | A1 |
20120246809 | Elam et al. | Oct 2012 | A1 |
20130097769 | Tuffery | Apr 2013 | A1 |
20130112211 | Power et al. | May 2013 | A1 |
20130269090 | Liu | Oct 2013 | A1 |
20130276217 | Patil et al. | Oct 2013 | A1 |
20140184407 | Palil et al. | Jul 2014 | A1 |
20150033437 | Hampton | Feb 2015 | A1 |
20150250234 | Tuffery et al. | Sep 2015 | A1 |
20150282543 | Rippert et al. | Oct 2015 | A1 |
20170100613 | Chessari et al. | Apr 2017 | A1 |
Number | Date | Country |
---|---|---|
2792282 | Apr 2013 | CA |
2730167 | Oct 2005 | CN |
1988936 | Jun 2007 | CN |
101001672 | Jul 2007 | CN |
103065698 | Apr 2013 | CN |
10315607 | Dec 2004 | DE |
0056613 | Jul 1982 | EP |
1516645 | Mar 2005 | EP |
2583721 | Apr 2014 | EP |
2829304 | Jan 2015 | EP |
2929913 | Apr 2016 | EP |
2583721 | Mar 2017 | EP |
3335765 | Jun 2018 | EP |
2573852 | Jun 2016 | ES |
2614538 | Nov 1998 | FR |
2899488 | Oct 2007 | FR |
2941624 | Aug 2010 | FR |
2401553 | Aug 2005 | GB |
2006012475 | Feb 2006 | WO |
2013056390 | Apr 2013 | WO |
Entry |
---|
Respirex International Ltd.; Airprotex FM; Product Data Sheet; Feb. 15, 2011; pp. 1-5. |
PPS Professional Protection Systems; PPS Product Data Sheet; Nuclear Powered Respirator Suit (NuPo Suit); Paper No. L0041-080711; pp. 1-2. |
EP12188062, European Search Report, dated Jan. 27, 2014, 2 pages. |
EP14163775, Partial European Search Report, dated Aug. 7, 2014, 4 pages. |
U.S. Appl. No. 14/680,221, Office Action, dated Jun. 13, 2016, 20 pages. |
EP12188062, Examination Report, dated Feb. 26, 2014, 5 pages. |
CN201210399325.2, Office Action, dated Oct. 27, 2016, 20 pages. |
CN201210399325.2, Office Action, dated Mar. 10, 2016, 20 pages. |
EP12188062, Intention to Grant, dated Nov. 2, 2016, 22 pages. |
EP12188062, Decision to Grant, dated Feb. 16, 2017, 2 pages. |
CN201210399325.2, Office Action, dated May 17, 2017, 5 pages. |
U.S. Appl. No. 13/278,439, Restriction Requirement, dated Dec. 19, 2013, 6 pages. |
U.S. Appl. No. 13/278,439, Office Action, dated Mar. 14, 2014, 14 pages. |
U.S. Appl. No. 13/278,439, Final Office Action, dated Sep. 24, 2014, 14 pages. |
U.S. Appl. No. 13/278,439, Advisory Action, dated Dec. 1, 2014, 3 pages. |
U.S. Appl. No. 13/278,439, Notice of Panel Decision from Pre-Appeal Brief Review, dated Jan. 12, 2015, 2 pages. |
U.S. Appl. No. 13/278,439, Examiner's Answer to Appeal Brief, dated Oct. 6, 2015, 10 pages. |
U.S. Appl. No. 13/278,439, Decision on Appeal, dated Sep. 14, 2017, 9 pages. |
U.S. Appl. No. 13/278,439, Notice of Allowance, dated Dec. 21, 2017, 7 pages. |
Canada Patent Application No. 2,792,282, Office Action, dated Jun. 26, 2018, 3 pages. |
CN201210399325.2, Notification to Grant Patent Right, dated Aug. 15, 2017, 5 pages. |
EP16204513.2, Extended European Search Report, dated May 29, 2017, 10 pages. |
U.S. Appl. No. 15/382,205, Restriction Requirement, dated Aug. 27, 2018, 6 pages. |
Annex to the communication dated Nov. 7, 2014 for EP Application No. 14163775. |
CN Search Report dated Mar. 2, 2016 for CN Application No. 2012103993252. |
Communication from the Examining Division dated Nov. 7, 2014 for EP Application No. 14163775. |
Decision to grant a European patent dated Mar 10, 2016 for EP Application No. 14163775. |
EP Office Action dated Nov. 7, 2014 for EP Application No. 14163775. |
European search report dated Oct. 23, 2014 for EP Application No. 14163775. |
Final Rejection dated Sep. 25, 2014 for U.S. Appl. No. 13/278,439. |
Intention to grant dated Nov. 23, 2015 for EP Application No. 14163775. |
Non-Final Rejection dated May 1, 2019 for U.S. Appl. No. 15/382,205. |
Notice of Allowance and Fees Due (PTOL-85) dated Apr. 20, 2018 for U.S. Appl. No. 13/278,439. |
Notice of Allowance and Fees Due (PTOL-85) dated Jun. 5, 2018 for U.S. Appl. No. 13/278,439. |
Notice of Allowance and Fees Due (PTOL-85) dated Mar. 2, 2020 for U.S. Appl. No. 15/382,205. |
Notice of Allowance and Fees Due (PTOL-85) dated Oct. 5, 2016 for U.S. Appl. No. 14/680,221. |
Annex to the communication dated Jan. 18, 2021 for EP Application No. 16204513. |
Communication from the Examining Division dated Jan. 18, 2021 for EP Application No. 16204513. |
Notice of Allowance and Fees Due (PTOL-85) dated Feb. 16, 2021 for U.S. Appl. No. 15/382,205. |
Number | Date | Country | |
---|---|---|---|
20180256924 A1 | Sep 2018 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13278439 | Oct 2011 | US |
Child | 15934421 | US |